Stay updated with breaking news from Pharmaxis Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clinical stage drug development company Pharmaxis Ltd (ASX: PXS) today announced it has completed dosing the first of three stages in its phase 1c clinical trial (MF‐101) studying a potential new treatment for the bone marrow cancer myelofibrosis. The study’s safety monitoring committee that advises on the study ...
The company’s PXS-5505 multinational trial in Myelofibrosis has been cleared by the safety committee to advance to the second stage of Dose escalation...
2021-05-03 by Proactive Australia Pharmaxis Ltd (ASX:PXS)(FRA:UUD) drug discovery PXS-5505 will be the focus of a new study funded by a grant from the Charlie Teo Foundation, an Australian charity, for key research into a drug discovery tackling an aggressive and deadly form of brain cancer. The drug, PXS-5505, which has commenced a phase 1/2a clinical trial for the rare bone marrow cancer myelofibrosis, will now enter pre-clinical efficacy testing for glioblastoma (GBM), the most common form of brain cancer with an average survival of only 15 months from diagnosis. A$186,837 research grant ...
Charlie Teo Foundation grant to fund key research of new Pharmaxis drug to tackle brain cancer PXS-5505 will enter pre-clinical efficacy testing for glioblastoma, the most common form of brain cancer with an average survival of only 15 months from diagnosis. Charlie Teo Foundation founder and director Professor Charlie Teo and Pharmaxis CEO Gary Phillips during a TV interview. Pharmaxis Ltd (ASX:PXS) (FRA:UUD) drug discovery PXS-5505 will be the focus of a new study funded by a grant from the Charlie Teo Foundation, an Australian charity, for key research into a drug discovery tac...
Inhalable Drugs Market 5 Global Inhalable Drugs Market, By Product Type (Aerosol, Dry Powder Formulation, Spray), Application (Respiratory Diseases, Non-Respiratory Diseases), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028 Inhalab...